Sites / Clinical Research Institute of Michigan
Is this you?

Request access for Clinical Research Institute of Michigan with your @researchmi.com work email. Intera will contact you to verify and set up your account — nothing auto-publishes.

Request account

Clinical Research Institute of Michigan

Unclaimed profile

Independent Site Network · Chesterfield, Michigan · ~2 sites

Intera lens
ICP 6Lift (cardio sample) 0.24Recruit soph 0.43
Quality Scorecard (1–100)
Overall77Recruit59Ops82Sponsor88Ther84

Performance (observed)

Historical trials
370
Completed
195
Terminated/Withdrawn
42
Completion rate
82%
Active now
123
Phase 2
121
Phase 3
191
Realized enrollment
268,503
First study year
1994
Years active
32
Match confidence
high
Enrollment velocity (inf)
8,391

Therapeutic

Areas
Gastroenterology, Internal medicine, Cardiology, Emergency medicine, Neurology, Vascular surgery, Oncology, Osteoporosis, Liver disease (hepatitis, NASH), Diabetes, Asthma, COPD, Overactive bladder
Specialties
Gastroenterology, IBD, IRS, NASH, Liver disease, Hepatitis
Breadth (conditions)
635
States
Michigan

Recruitment (web observed)

Trial Finder
Yes
Recruitment pages
Yes
Advertises recruitment
Yes
Capability notes
Multi-therapeutic trials across Metro Detroit area; partnerships with multiple physicians and facilities; experienced study coordinators (40+ years combined experience)

Relationships

Sponsors
National Cancer Institute (NCI); Pfizer; SWOG Cancer Research Network; AbbVie; Children's Oncology Group; Eli Lilly and Company
CROs
Clinipace Worldwide; Crohn's and Colitis Foundation; ICON Clinical Research; IQVIA Pty Ltd; Medpace, Inc.; MicroConstants
Partnerships
Multiple physician collaborations; Metro Detroit network
Owner / parent
Founded 2003 by Dr. Ronald P. Fogel (gastroenterologist); partnerships with Center for Digestive Health

Capacity & people

Investigators
Coordinators
CEO
Dr. Ronald P. Fogel
VP Clinical Ops
Dr. Ronald P. Fogel (President & CEO)
Emails
ksimons@researchmi.com

Tech & DCT

eSource
Yes
Builds tech
Vendors (FibroScan, EDC systems)
Tech stack
FibroScan liver assessment technology; EDC system experience (major systems); source document creation
Recruiting visible
Y

Notes

Multi-site research network with 6 active recruiting cardiometabolic trials confirmed (ClinicalTrials.gov validation). Founded 2003; experienced (200+ trials completed). Multi-therapeutic focus includes cardiology and diabetes. Strong coordination infrastructure with 40+ years combined research staff experience. Partnership model with multiple Metro Detroit physicians. Founder-led by nationally-renowned gastroenterology researcher. Score reflects: multi-therapeutic research capability, experienced team, cardiometabolic trials, growing trial portfolio; limited expansion (only 2 locations) and research focus on gastrointestinal disease may limit broader cardiometabolic positioning vs. dedicated cardio-metabolic sites.

Recommendation features (sample indication)

Ind fit 0.42Liftability 0.24Overall77

FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.